[HTML][HTML] Strategies to inhibit Myc and their clinical applicability
JR Whitfield, ME Beaulieu, L Soucek - Frontiers in cell and …, 2017 - frontiersin.org
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
Strategies to Inhibit Myc and Their Clinical Applicability.
JR Whitfield, ME Beaulieu, L Soucek - Frontiers in Cell and …, 2017 - europepmc.org
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
[引用][C] Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - Frontiers in Cell and …, 2017 - cir.nii.ac.jp
Strategies to Inhibit Myc and Their Clinical Applicability | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - Frontiers in Cell and …, 2017 - ddd.uab.cat
Myc is an oncogene deregulated in most-perhaps all-human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
[PDF][PDF] Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - academia.edu
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
[HTML][HTML] Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - Frontiers in Cell and …, 2017 - ncbi.nlm.nih.gov
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
[PDF][PDF] Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - core.ac.uk
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu, L Soucek - 2017 - lareferencia.info
Myc is an oncogene deregulated in most-perhaps all-human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
Strategies to Inhibit Myc and Their Clinical Applicability
JR Whitfield, ME Beaulieu… - Frontiers in cell and …, 2017 - pubmed.ncbi.nlm.nih.gov
Myc is an oncogene deregulated in most-perhaps all-human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …
Strategies to inhibit Myc and their clinical applicability
JR Whitfield, ME Beaulieu… - Frontiers in cell and …, 2017 - portalrecerca.uab.cat
Abstract© 2017 Whitfield, Beaulieu and Soucek. Myc is an oncogene deregulated in most-
perhaps all-human cancers. Each Myc family member, c-, L-, and N-Myc, has been …
perhaps all-human cancers. Each Myc family member, c-, L-, and N-Myc, has been …